Posted September 11, 2020
Stat News reports that the large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom. An individual familiar with the development said researchers had been told the hold was placed on the trial out of “an abundance of caution.” Read more.